What antibiotic should be given to a patient presenting with dysuria and hematuria, suggesting a possible urinary tract infection (UTI), with no known history of sulfa allergy or other contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Selection for Dysuria and Hematuria

For a patient presenting with dysuria and hematuria suggesting uncomplicated cystitis, nitrofurantoin (100 mg twice daily for 5 days) is the first-line treatment, with fosfomycin (3 g single dose) as an equally appropriate alternative. 1, 2

Clinical Context and Diagnosis

The combination of dysuria and hematuria strongly suggests acute bacterial cystitis, particularly in women without complicating factors. 3 Before initiating treatment, you must determine whether this is uncomplicated or complicated:

  • Uncomplicated cystitis: Otherwise healthy, non-pregnant women with no anatomical/functional urinary tract abnormalities 1
  • Complicated UTI: Presence of male sex, pregnancy, catheter, structural abnormalities, recent instrumentation, immunosuppression, or diabetes 4, 5

All UTIs in men are considered complicated and require 14 days of treatment, as prostatitis cannot be initially excluded. 4

First-Line Treatment Options for Uncomplicated Cystitis

Preferred Agents

  • Nitrofurantoin: 100 mg orally twice daily for 5 days 1, 2, 3

    • Maintains excellent sensitivity against most uropathogens 3
    • Minimal collateral damage and resistance development 2, 3
    • Avoid in patients with creatinine clearance <30 mL/min 6
  • Fosfomycin tromethamine: 3 g single oral dose 1, 2, 3

    • Convenient single-dose therapy with high patient compliance 2
    • Effective against ESBL-producing organisms 2, 7
    • Particularly useful when resistance patterns are unknown 1

Second-Line Options (When First-Line Unavailable)

  • Trimethoprim-sulfamethoxazole: 160/800 mg (double-strength) twice daily for 3 days 1
    • Only use if local resistance rates are <20% 1, 3
    • Obtain urine culture if empirically used in areas with unknown resistance 1
    • High resistance rates in many communities now preclude routine use 2, 7

Treatment for Complicated UTI or Pyelonephritis

If the patient has fever, costovertebral angle tenderness, systemic symptoms, or complicating factors, this represents pyelonephritis or complicated UTI requiring different management:

Outpatient Treatment (No Hospitalization Required)

  • Ciprofloxacin: 500 mg orally twice daily for 7 days 1

    • Only if local fluoroquinolone resistance is <10% 1
    • If resistance >10%, give initial IV ceftriaxone 1 g before starting oral therapy 1
  • Levofloxacin: 750 mg orally once daily for 5 days 1

    • Same resistance threshold considerations apply 1

Alternative for Complicated UTI

  • Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 14 days 1
    • Only if organism known to be susceptible 1
    • If susceptibility unknown, give initial IV ceftriaxone 1 g or aminoglycoside 1

Duration Considerations

  • Uncomplicated cystitis: 3-5 days 1, 2
  • Complicated UTI: 7-14 days 4, 5
  • Men (prostatitis cannot be excluded): Minimum 14 days 4
  • Pyelonephritis: 7-14 days depending on agent 1

Critical Pitfalls to Avoid

Do not treat asymptomatic bacteriuria except in pregnancy or before invasive urological procedures. 1, 4 This increases resistance without clinical benefit and is a common error in older adults with positive urine cultures but no UTI symptoms. 1

Fluoroquinolones should not be used as first-line for uncomplicated cystitis due to increasing resistance rates and the need to preserve these agents for complicated infections. 1, 2, 7 The high resistance rates in many communities (often >10%) make empiric use problematic. 1

Beta-lactams (including amoxicillin-clavulanate) are less effective than other agents for pyelonephritis and should only be used with initial parenteral therapy if chosen. 1

Special Populations

Older Adults

Antimicrobial treatment in older patients follows the same principles as other age groups, using identical antibiotics and durations unless complicating factors exist. 1 Fosfomycin, nitrofurantoin, pivmecillinam, fluoroquinolones, and trimethoprim-sulfamethoxazole show only slight, insignificant age-associated resistance effects. 1

Pregnancy

Beta-lactams, nitrofurantoin, fosfomycin, and trimethoprim-sulfamethoxazole are appropriate treatments in pregnancy. 3 All UTIs in pregnancy are considered complicated and require urine culture. 5

When to Obtain Urine Culture

Always obtain urine culture before treatment in:

  • Suspected pyelonephritis 1
  • Complicated UTI 4, 5
  • Pregnancy 5
  • Men (all UTIs) 4
  • Failed initial therapy 5
  • Recurrent infections 4

For uncomplicated cystitis in women with typical symptoms, empiric treatment without culture is acceptable if using first-line agents. 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and treatment of urinary tract infections across age groups.

American journal of obstetrics and gynecology, 2018

Guideline

Tratamiento para Infección de Vías Urinarias Complicada

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Complicated Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.